NDC 72516-024

Papaverine Hydrochloride

Papaverine Hydrochloride

Papaverine Hydrochloride is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Oryza Pharmaceuticals Inc.. The primary component is Papaverine Hydrochloride.

Product ID72516-024_160e9fb1-4feb-45d6-84d7-14244a9501cf
NDC72516-024
Product TypeHuman Prescription Drug
Proprietary NamePapaverine Hydrochloride
Generic NamePapaverine Hydrochloride
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-02-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameOryza Pharmaceuticals Inc.
Substance NamePAPAVERINE HYDROCHLORIDE
Active Ingredient Strength30 mg/mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 72516-024-10

10 VIAL in 1 CARTON (72516-024-10) > 2 mL in 1 VIAL
Marketing Start Date2021-02-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Papaverine Hydrochloride" or generic name "Papaverine Hydrochloride"

NDCBrand NameGeneric Name
0517-4002Papaverine HydrochloridePapaverine Hydrochloride
14789-121Papaverine HydrochloridePapaverine Hydrochloride
54288-142PAPAVERINE HYDROCHLORIDEPapaverine Hydrochloride
72516-024Papaverine HydrochloridePapaverine Hydrochloride

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.